CAS: 1234708-04-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | hPGDS-IN-1 REF: 54-BUP12291CAS: 1234708-04-3 | 99.73% | 694.00 €~3,135.00 € | Mon 21 Apr 25 |
 | hPGDS-IN-1 REF: TM-T2681CAS: 1234708-04-3 | 100% - 99.74% | 80.00 €~2,274.00 € | Thu 24 Apr 25 |
 | SAR191801 REF: IN-DA009CIBCAS: 1234708-04-3 | 98% | - - - | Discontinued product |
 | SAR191801 REF: 3D-JZB70804CAS: 1234708-04-3 | Min. 95% | - - - | Discontinued product |
Ref: 54-BUP12291
| 1g | 3,135.00 € | ||
| 25mg | 694.00 € | ||
| 50mg | 1,039.00 € | ||
| 100mg | 1,270.00 € | ||
| 500mg | 2,323.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
hPGDS-IN-1
CAS:1234708-04-3
hPGDS-IN-1 is a hPGDS inhibitor.
Formula:
C22H20N6O3
Purity:
100% - 99.74%
Color and Shape:
Solid
Molecular weight:
416.43
Ref: TM-T2681
| 1mg | 80.00 € | ||
| 5mg | 160.00 € | ||
| 10mg | 250.00 € | ||
| 25mg | 465.00 € | ||
| 50mg | 707.00 € | ||
| 100mg | 938.00 € | ||
| 1mL*10mM (DMSO) | 170.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
Ref: IN-DA009CIB
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 500mg | Discontinued | Request information |
SAR191801
CAS:1234708-04-3
Please enquire for more information about SAR191801 including the price, delivery time and more detailed …
Formula:
C22H20N6O3
Purity:
Min. 95%
Molecular weight:
416.43 g/mol
Ref: 3D-JZB70804
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
